Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comprehensive magnetic resonance of peripheral arterial disease

Trial Profile

Comprehensive magnetic resonance of peripheral arterial disease

Phase of Trial: Phase III

Latest Information Update: 23 Aug 2017

At a glance

  • Drugs Ezetimibe (Primary) ; Ezetimibe/simvastatin (Primary) ; Simvastatin (Primary)
  • Indications Atherosclerosis; Peripheral arterial disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2012 Actual patient number changed from 67 to 85 as reported by ClinicalTrials.gov.
    • 02 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Oct 2011 Actual patient numbers changed to 67 as reported in Atherosclerosis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top